Literature DB >> 1687600

The prognostic value of tumor-associated carbohydrate structures correlated with gene amplifications in human breast carcinomas.

T Fukutomi1, S Hirohashi, H Tsuda, T Nanasawa, H Yamamoto, M Itabashi, Y Shimosato.   

Abstract

The effects of cell surface sugar chains combined with certain gene amplifications of breast cancers on the prognosis of patients were studied and the relationships between the sugar chains of cancer cells and amplifications of the proto-oncogenes c-myc, int-2 and c-erb B-2, evaluated. One hundred and fifty three human breast carcinoma tissues were investigated by an immunohistochemical technique using the avidinbiotin-peroxidase method with 1 lectin (HPA; Helix Pomatia) and 4 monoclonal antibodies (B-72-3, St-439, anti-Tn and anti-T). The positive rates of HPA, St-439, B-72-3, anti-Tn and anti-T were 43 per cent (63/153), 52 per cent (80/153), 53 per cent (81/153), 64 per cent (98/153) and 89 per cent (136/153), respectively. Patients whose cancers had positive HPA staining were found to have a lower survival rate than those with negative HPA staining (p less than 0.05), whereas those whose cancers had positive St-439 staining showed a better prognosis than those with negative St-439 staining (p less than 0.01). The positive rate of HPA was related to the gene amplification of c-myc proto-oncogene (p less than 0.01), whereas the negative rate of St-439 was correlated with the gene amplification of c-erb B-2 (p less than 0.01). These data indicate the prognostic value of HPA and St-439 and also the relationships between the gene amplifications and carbohydrate structures in breast cancer cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1687600     DOI: 10.1007/bf02470985

Source DB:  PubMed          Journal:  Jpn J Surg        ISSN: 0047-1909


  29 in total

Review 1.  Tumor invasion and metastases--role of the extracellular matrix: Rhoads Memorial Award lecture.

Authors:  L A Liotta
Journal:  Cancer Res       Date:  1986-01       Impact factor: 12.701

2.  Node-negative breast cancer treated by modified radical mastectomy without adjuvant therapies: variables associated with disease recurrence and survivorship.

Authors:  R A Huseby; H E Ownby; J Frederick; S Brooks; J Russo; M J Brennan
Journal:  J Clin Oncol       Date:  1988-01       Impact factor: 44.544

3.  Proto-oncogene structure and breast cancer prognosis.

Authors:  M V Viola
Journal:  J Clin Oncol       Date:  1987-07       Impact factor: 44.544

Review 4.  Cancer metastasis. Organ colonization and the cell-surface properties of malignant cells.

Authors:  G L Nicolson
Journal:  Biochim Biophys Acta       Date:  1982-12-21

5.  Correlation between long-term survival in breast cancer patients and amplification of two putative oncogene-coamplification units: hst-1/int-2 and c-erbB-2/ear-1.

Authors:  H Tsuda; S Hirohashi; Y Shimosato; T Hirota; S Tsugane; H Yamamoto; N Miyajima; K Toyoshima; T Yamamoto; J Yokota
Journal:  Cancer Res       Date:  1989-06-01       Impact factor: 12.701

6.  Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene.

Authors:  D J Slamon; G M Clark; S G Wong; W J Levin; A Ullrich; W L McGuire
Journal:  Science       Date:  1987-01-09       Impact factor: 47.728

7.  Proto-oncogene abnormalities in human breast cancer: correlations with anatomic features and clinical course of disease.

Authors:  M J Cline; H Battifora; J Yokota
Journal:  J Clin Oncol       Date:  1987-07       Impact factor: 44.544

8.  Nuclear DNA content and prognosis in human breast cancer: a static cytophotometric study.

Authors:  J Harvey; N de Klerk; I Berryman; G Sterrett; M Byrne; J Papadimitriou
Journal:  Breast Cancer Res Treat       Date:  1987       Impact factor: 4.872

9.  Cell surface glycoproteins of 13762NF mammary adenocarcinoma clones of differing metastatic potentials.

Authors:  P A Steck; G L Nicolson
Journal:  Exp Cell Res       Date:  1983-09       Impact factor: 3.905

10.  Preparation and characterization of monoclonal antibodies directed to the tumor-associated O-linked sialosyl-2----6 alpha-N-acetylgalactosaminyl (sialosyl-Tn) epitope.

Authors:  T Kjeldsen; H Clausen; S Hirohashi; T Ogawa; H Iijima; S Hakomori
Journal:  Cancer Res       Date:  1988-04-15       Impact factor: 12.701

View more
  6 in total

1.  Cloning, expression and gene organization of a human Neu5Ac alpha 2-3Gal beta 1-3GalNAc alpha 2,6-sialyltransferase: hST6GalNAcIV.

Authors:  A Harduin-Lepers; D C Stokes; W F Steelant; B Samyn-Petit; M A Krzewinski-Recchi; V Vallejo-Ruiz; J P Zanetta; C Augé; P Delannoy
Journal:  Biochem J       Date:  2000-11-15       Impact factor: 3.857

2.  Serum IgA1 shows increased levels of α2,6-linked sialic acid in breast cancer.

Authors:  Hannah J Lomax-Browne; Claire Robertson; Aristotelis Antonopoulos; Anthony J C Leathem; Stuart M Haslam; Anne Dell; Miriam V Dwek
Journal:  Interface Focus       Date:  2019-02-15       Impact factor: 3.906

3.  Helix pomatia and prognosis of breast cancer.

Authors:  R A Walker
Journal:  Br J Cancer       Date:  1993-09       Impact factor: 7.640

4.  GalNAc glycoprotein expression by breast cell lines, primary breast cancer and normal breast epithelial membrane.

Authors:  S A Brooks; D M Hall; I Buley
Journal:  Br J Cancer       Date:  2001-09-28       Impact factor: 7.640

5.  Helix pomatia agglutinin binding in human tumour cell lines: correlation with pulmonary metastases in nude mice.

Authors:  I Kjønniksen; P D Rye; O Fodstad
Journal:  Br J Cancer       Date:  1994-06       Impact factor: 7.640

6.  A tumour-associated cell-surface glycoprotein accompanying p53 overexpression and higher growth potential for gastric cancer.

Authors:  Y Maehara; T Okuyama; Y Kakeji; K Endo; M Yamamoto; K Sugimachi
Journal:  Br J Cancer       Date:  1995-05       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.